Hello, you must certainly remember the first phase of COVID, when there was chaos among the infectious disease experts, with each one giving their long ...
With a projected 15–20% revenue growth in 2024-25, improving margins, and diversification into high-growth segments, this company is setting the stage for sustained outperformance.